Publicacions destacades

EULAR recommendations for a core dataset to support clinical care and translational and observational research in systemic lupus erythematosus

Mucke, J; Bertsias, G; Aringer, M; Arnaud, L; Bostrom, C;

(...)

Vital, EM; Van Vollenhoven, R; Wincup, C; Schneider, M; Tas.

Referència:
ANNALS OF THE RHEUMATIC DISEASES 2025.
Oral roflumilast for the treatment of chronic hand eczema: A retrospective case series.

Gomez-Martinez S; Amat-Samaranch V; Lasheras-Pérez MA; Rodríguez-Serna M; Mascaró JM;

Riquelme-Mc Loughlin C.

Referència:
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 2025.
Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data.

Rua-Figueroa I; Cervera R; Freire-González M; Turrión Nieves AI; Cortés-Hernández J;

(...)

Diaz-Encarnación M; Ding B; Galvez-Fernandez M; Bahamontes-Rosa N; Pego-Reigosa JM;.

Referència:
Lupus Science and Medicine 2025.
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

Arnaud, L; Ruiz-Irastorza, G; Aranow, C; Bernatsky, S; Dall'Era, M;

(...)

Vital, EM; Gerosa, M; Touma, Z; Mosca, M; Tani, C.

Referència:
Lancet Rheumatology, The 2025.
2023 International Rome consensus for the nomenclature of Sjögren disease

Ramos-Casals, Manuel; Baer, Alan N; Brito-Zeron, Maria del Pilar; Hammitt, Katherine M; Bouillot, Coralie;

(...)

Valim, Valeria; Vitali, Claudio; Vivino, Frederick; Wahren-Herlenius, Marie; Moutsopoulos, Haralampos M.

Referència:
Nature Reviews Rheumatology 2025.
Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: Clinical and therapeutic implications

Gomez-Caverzaschi, Veronica; Yague, Jordi; Espinosa, Gerard; Mayordomo-Bofill, Isabet; Bedon-Galarza, Ricardo;

(...)

Vilaseca, Isabel; Cervera, Ricard; Arostegui, Juan I; Mensa-Vilaro, Anna; Hernandez-Rodriguez, Jose.

Referència:
AUTOIMMUNITY REVIEWS 2024.
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

Parodis, I; Lindblom, J; Barturen, G; Ortega-Castro, R; Cervera, R;

(...)

Vasconcelos, C; Vigone, B; Witte, T; Alarcón-Riquelme, ME; Beretta, L.

Referència:
ANNALS OF THE RHEUMATIC DISEASES 2024.
Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the "CAPS registry "

Pons, I; Jeréz, A; Espinosa, G; Rodríguez-Pintó, I; Erkan, D;

Shoenfeld, Y; Cervera, R.

Referència:
SEMINARS IN ARTHRITIS AND RHEUMATISM 2024.
Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis

Fernandes-Serodio, J; Prieto-González, S; Espígol-Frigolé, G; Ríos-Garcés, R; Gómez-Caverzaschi, V;

(...)

Grau, JM; Vilaseca, I; Alobid, I; Cid, MC; Hernández-Rodríguez, J.

Referència:
JOURNAL OF INTERNAL MEDICINE 2024.
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Fanouriakis, A; Kostopoulou, M; Andersen, J; Aringer, M; Arnaud, L;

(...)

Vital, EM; van Vollenhoven, RF; Wincup, C; Bertsias, G; Boumpas, DT.

Referència:
ANNALS OF THE RHEUMATIC DISEASES 2024.